Permax Recall
- Date: 2007-04-30 - Word Count: 512
Share This!
Following two recent studies, the Federal Drug Administration (FDA) announced a Permax recall on March 29, 2007. The Permax recall includes both the name brand Permax (peroglide) and the generic versions of peroglide. Current studies have revealed Permax heart valve disease in around one-fourth of Parkinson's patients who have taken Permax over an extended period of time.
Permax Valvulopathy (valve injuries) first came to the attention of the Federal Drug Administration (FDA) in 2002. Permax was approved by the FDA in 1988. Prior to the Permax recall, the FDA added a black box warning regarding the risk of serious heart valve damage.
Permax side effects including heart valve damage were revealed in the studies published in the New England Journal of Medicine (NEJM). High rates of valve leakage were found in up to 20% of patients prescribed Permax. Dr. Robert Temple, the associate director for medical policy at the Center for Drug Evaluation and Research, stated that Permax (Peroglide) was linked with a fivefold increase in regurgitation of the mitral, atrial, or tricuspid valves compared with the general population. The side effects revealed in these studies were further evidence of the ongoing problems leading to the Permax recall.
Permax, which is also known as Peroglide, is used in the treatment of Parkinson's patients and also for a condition called Restless Legs Syndrome (RLS). Parkinson's disease is caused by the degeneration of neurons in an area of the brain involved with movement control that results in a progressive neurological disorder. Restless legs syndrome is also a neurological condition, however it is often misdiagnosed even though it affects around 2.7% of people in the United States. Permax heart valve damage has been reported in both Parkinson's and Restless Legs Syndrome patients around the United States. The Permax recall is expected to affect the future treatment of both Parkinson's and RLS patients.
Permax was released in 1989 after being developed by Eli Lilly. Over 500,000 people have taken Permax since 1989 to treat Parkinson's and RLS. Two European studies were conducted in Britain and Italy. In the Italian study, of the 155 people who had taken Permax, 23.4% of them developed Permax heart problems. The British study involved 11,417 people who were taking the drug. Patients in the British study were 37 times more probable to develop Permax heart damage problems. Serious Permax heart valve disease has also been reported by the Mayo Clinic in patients who took the drug and were later diagnosed with heart problems.
The FDA has announced that due to the Permax recall patients with Parkinson's should:
• Contact their healthcare professional to discuss alternate treatment options.
• NOT stop taking Peroglide (Permax) without consulting their healthcare professional, since stopping Permax can be dangerous and several other effective treatments are available.
The FDA has stated that the effect of the Permax recall will not be immediate. There will be a delay which will allow doctors and patients to arrange for appropriate replacement treatment options. Following the Permax recall, the companies that manufacture and distribute peroglide (Permax) are cooperating with the FDA in the removal of the drug from the marketplace.
Permax Valvulopathy (valve injuries) first came to the attention of the Federal Drug Administration (FDA) in 2002. Permax was approved by the FDA in 1988. Prior to the Permax recall, the FDA added a black box warning regarding the risk of serious heart valve damage.
Permax side effects including heart valve damage were revealed in the studies published in the New England Journal of Medicine (NEJM). High rates of valve leakage were found in up to 20% of patients prescribed Permax. Dr. Robert Temple, the associate director for medical policy at the Center for Drug Evaluation and Research, stated that Permax (Peroglide) was linked with a fivefold increase in regurgitation of the mitral, atrial, or tricuspid valves compared with the general population. The side effects revealed in these studies were further evidence of the ongoing problems leading to the Permax recall.
Permax, which is also known as Peroglide, is used in the treatment of Parkinson's patients and also for a condition called Restless Legs Syndrome (RLS). Parkinson's disease is caused by the degeneration of neurons in an area of the brain involved with movement control that results in a progressive neurological disorder. Restless legs syndrome is also a neurological condition, however it is often misdiagnosed even though it affects around 2.7% of people in the United States. Permax heart valve damage has been reported in both Parkinson's and Restless Legs Syndrome patients around the United States. The Permax recall is expected to affect the future treatment of both Parkinson's and RLS patients.
Permax was released in 1989 after being developed by Eli Lilly. Over 500,000 people have taken Permax since 1989 to treat Parkinson's and RLS. Two European studies were conducted in Britain and Italy. In the Italian study, of the 155 people who had taken Permax, 23.4% of them developed Permax heart problems. The British study involved 11,417 people who were taking the drug. Patients in the British study were 37 times more probable to develop Permax heart damage problems. Serious Permax heart valve disease has also been reported by the Mayo Clinic in patients who took the drug and were later diagnosed with heart problems.
The FDA has announced that due to the Permax recall patients with Parkinson's should:
• Contact their healthcare professional to discuss alternate treatment options.
• NOT stop taking Peroglide (Permax) without consulting their healthcare professional, since stopping Permax can be dangerous and several other effective treatments are available.
The FDA has stated that the effect of the Permax recall will not be immediate. There will be a delay which will allow doctors and patients to arrange for appropriate replacement treatment options. Following the Permax recall, the companies that manufacture and distribute peroglide (Permax) are cooperating with the FDA in the removal of the drug from the marketplace.
Related Tags: parkinsons, restless legs syndrome, permax recall, peroglide recall, permax lawyer, heart valve damage, heart valve disease
Steve FieldsTo learn more about Permax Recall please visit our website.Our team of Permax lawyers represents clients in Minnesota, Wisconsin, Iowa, Arizona, North Dakota and South Dakota. Your Article Search Directory : Find in Articles
Recent articles in this category:
- Work Cover Lawyers Help Workers Favored In New Contingency Agreement
Were you ever given a small amount of compensation after having been injured on your job? Have exper - Florida Last Will And Testament Information
A person who is at least 18 years of age can complete a Florida Last Will and Testament and is refer - Florida Durable Power Of Attorney Information
A Florida durable power of attorney is a legal document that designates a person to act on behalf of - California Power Of Attorney Information
In California any adult person who has the ability to enter into an agreement can complete and sign - Criminal Lawyer
Sexual assaults are increasing with alarming frequency and everyday there are news reports about var - Fort Lauderdale Foreclosure Lawyer Explains, Foreclosure Is Not Your Only Option, You Have A Choice
Foreclosure has been one of the foremost topics within the real estate world in recent years, as eac - Should You Make A Personal Injury Claim?
Personal injury claims now gain wider exposure than ever before, yet many people are still unaware o - Mesa Bankruptcy- Regain Financial Stability
Are you drowning in overwhelming debt? Is it causing you mental, emotional and physical distress? Ta - How Bankruptcy Can Help You Financially Start Over With A Clean Slate
Fed up with debt? Desperately want to be free from the unbearable problem? If yes, then you should n - Major Yasmin Birth Control Side Effects
Yasmin is a popular form of hormonal birth control that has been heavily marketed, especially to you
Most viewed articles in this category:
- Be Aware of Single Owner LLC Tax Problems
One of the more popular business entity choices these days is the limited liability company. If - 14 Tips on How Parents Who Have a Child with a Disability Can Organize Their Estate
Copyright © 2007 L. Mark Russell As a general rule, parents should keep their original document - IF OUR PETS WERE REALY OUR "MINOR CHILDREN" MOST OF US "PARENTS" WOULD BE IN JAIL FOR CHILD NEGLECT
As a pet owner, do you need to have a pet trust or will in your estate plan? Well, maybe so, given - The Last Will And Testament - A Model NOT To Live By
The death of Anna Nicole Smith has at least one valuable outcome, even if it is simply serving as a - The British Constitutional Reform Act
The Constitutional Reform Act of 2005 changed the British hitherto unwritten constitution by in - Patented Drugs
While a drug or process is under patent, other companies are wary of working anything even remote - Divorce and Debt
As common sense and statistics tell us, the leading cause of marital discord is money. Therefore - The Misunderstood World of Corporate Minutes
The corporation is the most used form of business entity in the United States. While many people - Attorney for Legal Services
All of us hire lawyers at one point or the other. People get sued, arrested, charged for a crime, - Should Parents EVER Leave an Inheritance Outright to a Child who has a Disability?
Copyright © 2007 L. Mark Russell There are few absolutes in estate planning, but this is one. I